Clonal Hematopoiesis
Key result
CHIP is linked to ~2-fold higher risk of CAD and ischemic stroke independent of traditional factors.
Why the study?
Clonal hematopoiesis of indeterminate potential (CHIP) is a novel cardiovascular risk factor associated with increased risk of coronary heart disease, ischemic stroke, and worsened heart failure outcomes independent of traditional risk factors, creating clinical management challenges.
Population
Individuals with clonal hematopoiesis of indeterminate potential (CHIP)
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
CHIP is a novel, potent non-traditional cardiovascular risk factor that doubles the risk of coronary heart disease and ischemic stroke, necessitating multidisciplinary management strategies.
Key Points
- Summarize the clinical impact of clonal hematopoiesis of indeterminate potential on cardiovascular risk and outline strategies for screening, evaluation, and multidisciplinary care.
- Synthesized mechanistic and clinical evidence evaluating clonal hematopoiesis of indeterminate potential (CHIP) as a non-traditional cardiovascular risk factor.
- Assessed clinical quandaries across hematology, oncology, and cardiology to highlight knowledge gaps and propose management recommendations.
- Somatic mutations in hematopoietic stem cells produce mutant leukocytes that independently double the risk of coronary heart disease and ischemic stroke.
- CHIP exacerbates heart failure outcomes independent of traditional cardiovascular risk factors.
- Evidence-based guidelines are currently lacking for targeted screening, cardiovascular risk stratification, and therapeutic management in affected patients.
Structured PICO
P
Population
Individuals with clonal hematopoiesis of indeterminate potential (CHIP)
CHIP is a novel, potent non-traditional cardiovascular risk factor that doubles the risk of coronary heart disease and ischemic stroke, necessitating multidisciplinary management strategies.
Limitations
- Absence of an evidence base to guide management of excess cardiovascular risk
- Current knowledge gaps
Cite This Study
Libby et al. (2019) conducted a review in Clonal hematopoiesis of indeterminate potential (CHIP). Clonal hematopoiesis of indeterminate potential (CHIP) was evaluated. Clonal hematopoiesis of indeterminate potential (CHIP) is associated with a doubled risk of coronary heart disease and ischemic stroke, independent of traditional cardiovascular risk factors.